The global regenerative medicine market is expected to grow significantly, reaching USD 1,69,586 million by 2034, up from USD ...

Recent years have seen swift expansion in the size of the tissue regeneration scaffold market. There is projected growth from $2.24 billion in 2024 to $2.61 billion in 2025, showing a compound annual ...

Take a look at 8 wealthy tech executives on a quest for the fountain of youth.

Scientists bioprint living muscle-tendon units that contract for months, offering promise for robotics, prosthetics, and ...

Transplanted mouse and human organoids showed kidney-like functions like blood filtration, protein uptake, and urine production.

Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...

Osteoarthritis (OA) remains one of the leading causes of disability worldwide, yet the therapeutic landscape is evolving ...

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys.

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys.

CollPlant Biotechnologies (NASDAQ: CLGN), or ‘ CollPlant ‘, a regenerative and aesthetics medicine company developing ...